Tom Ingless has over 7 years of experience in regulatory affairs throughout the healthcare industry, with a focus on successful MDR and IVDR transitions. Tom's background includes authoring high quality technical files and CERs; devising and implementing risk management processes; registrations and lifecycle management in the EU and Middle East; preparing devices for UKCA-marking. As a Senior Consultant, Tom focusses on compliance with European regulations and is part of Emergo's clinical evaluation and authorised representative programmes. Prior to joining Emergo, Tom held positions at Tristel Solutions, Oxford Gene Technology (part of the Sysmex Group) and Mundipharma Research.